Genenta Science S.p.A R&D Spending Growth & History (GNTA)
Genenta Science S.p.A's r&d spending was €2.7M for fiscal 2025.
View full Genenta Science S.p.A company overviewGenenta Science S.p.A annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.7M | −€2.1M | −43.75% |
| 2024 | 2024-12-31 | €4.8M | −€1.7M | −26.15% |
| 2023 | 2023-12-31 | €6.5M | €1.2M | +21.75% |
| 2022 | 2022-12-31 | €5.3M | €1.9M | +57.46% |
| 2021 | 2021-12-31 | €3.4M | −€1.3M | −27.68% |
| 2020 | 2020-12-31 | €4.7M | €985,479 | +26.61% |
| 2019 | 2019-12-31 | €3.7M | — | — |
Genenta Science S.p.A quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2022 | 2022-04-27 | €158,000 | — | — |
Genenta Science S.p.A r&d spending trends
Over the last five fiscal years, Genenta Science S.p.A's r&d spending decreased from €4.7M to €2.7M, a change of −€2.0M. The latest reported quarter, Q1 2022, shows €158,000.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genenta Science S.p.A source filings ↗